TFG Advisers’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,753
Closed -$220K 198
2024
Q1
$220K Sell
2,753
-118
-4% -$9.01K 0.09% 194
2023
Q4
$227K Sell
2,871
-223
-7% -$15.9K 0.1% 184
2023
Q3
$216K Buy
3,094
+19
+0.6% +$1.35K 0.1% 181
2023
Q2
$213K Sell
3,075
-180
-6% -$12.8K 0.1% 189
2023
Q1
$242K Sell
3,255
-904
-22% -$75.8K 0.12% 178
2022
Q4
$388K Buy
4,159
+16
+0.4% +$1.54K 0.2% 116
2022
Q3
$395K Buy
4,143
+62
+2% +$6.14K 0.22% 112
2022
Q2
$378K Buy
4,081
+15
+0.4% +$1.46K 0.2% 119
2022
Q1
$412K Buy
4,066
+113
+3% +$11.9K 0.19% 125
2021
Q4
$408K Buy
3,953
+13
+0.3% +$1.2K 0.18% 132
2021
Q3
$334K Buy
3,940
+14
+0.4% +$1.17K 0.16% 143
2021
Q2
$328K Sell
3,926
-99
-2% -$8.11K 0.16% 142
2021
Q1
$303K Sell
4,025
-107
-3% -$7.79K 0.16% 147
2020
Q4
$282K Buy
4,132
+24
+0.6% +$1.56K 0.15% 149
2020
Q3
$239K Buy
4,108
+196
+5% +$12.2K 0.14% 152
2020
Q2
$254K Buy
+3,912
New +$246K 0.16% 135
2020
Q1
Sell
-3,143
Closed -$233K 207
2019
Q4
$233K Buy
+3,143
New +$221K 0.13% 146

Other funds holding CVS

TFG Advisers's CVS Position: Q2 2024 in Review

TFG Advisers sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,753 shares — an estimated $220K sold.

TFG Advisers first reported a position in CVS in Q4 2019 and held it in 17 quarters. The position peaked at $412K in Q1 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • TFG Advisers reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • TFG Advisers sold 2,753 CVS Health shares in Q2 2024, an estimated $220K.
  • TFG Advisers first reported a position in CVS Health in Q4 2019 and held it in 17 quarters.
  • TFG Advisers's CVS Health position peaked at $412K in Q1 2022.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on TFG Advisers's 13F filing for Q2 2024, filed 25 Jul 2024.